{"id":"blephamide","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["sulfacetamide sodium 10%/prednisolone acetate 0.2%, Allergan, Inc."],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"69465827-dd70-483e-84c7-ced49af5d189","title":"BLEPHAMIDE (SULFACETAMIDE SODIUM AND PREDNISOLONE ACETATE) SUSPENSION/ DROPS [PHYSICIANS TOTAL CARE, INC.]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:28:41.941Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03694015","phase":"NA","title":"SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases","status":"TERMINATED","sponsor":"British Columbia Cancer Agency","startDate":"2019-12-02","conditions":"Neoplasm Metastasis, Neoplastic Processes, Neoplasms","enrollment":160},{"nctId":"NCT05668351","phase":"NA","title":"Stereotactic Ablative Radiation Therapy for Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2023-05-12","conditions":"Prostate Cancer","enrollment":42},{"nctId":"NCT02256969","phase":"PHASE4","title":"Intraductal Meibomian Gland Probing Trial","status":"COMPLETED","sponsor":"Joseph B. Ciolino, MD","startDate":"2014-10","conditions":"Meibomian Gland Dysfunction","enrollment":45},{"nctId":"NCT01001728","phase":"PHASE3","title":"SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2008-11","conditions":"Breast Cancer","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":5,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Blephamide","genericName":"Blephamide","companyName":"Joseph B. Ciolino, MD","companyId":"joseph-b-ciolino-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}